Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

The FDA should strengthen the evidence required for the approval of drugs under its accelerated pathway and increase the ...

Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. | ...

The Biotechnology Innovation Organization (BIO) has started the nationwide “​The Fight of Our Lives” campaign, creating a ...

Healthcare technology company Verily Health has kicked off its first major national campaign, the latest step in a mission to ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

Roche is launching a new global phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in ...

The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary ...

Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as Olixir New York ...

Apart from Daiichi, a growing number of drugmakers have elected to part ways with their over-the-counter businesses in recent ...

Viatris and Teva Pharmaceutical Industries recently launched separate recalls in the U.S. related to dissolution problems for ...

The FDA’s Pharmacy Compounding Advisory Committee will meet this summer to discuss whether certain peptides from compounding ...